Experimental Biology and Medicine, 245(15), 14171425
P.DelgadilloI.SaraivaJ
BPC 157, also known as PLD-116, PL-10, PL14736 [9], or Bepectin [10,11,12,13,14,15,16,17], has recently attracted considerable attention as a potential drug candidate that is stable in acidic environments and has no serious adverse effects [18], although it has been known to cause pain and/or necrosis when injected in an aqueous solution or in physiological saline [19]
it is a primary readout in kinase signaling pathway research
Exceptionally bioavailable, stable through digestion
Acknowledgements The CorEvitas Psoriasis Registry was developed in collaboration with the National Psoriasis Foundation (NPF)